Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004023448 | SCV004095328 | uncertain significance | Cardiovascular phenotype | 2023-08-28 | criteria provided, single submitter | clinical testing | The c.76G>A (p.A26T) alteration is located in exon 1 (coding exon 1) of the PCSK9 gene. This alteration results from a G to A substitution at nucleotide position 76, causing the alanine (A) at amino acid position 26 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005056100 | SCV005726860 | uncertain significance | not specified | 2024-11-10 | criteria provided, single submitter | clinical testing | |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508903 | SCV000606674 | pathogenic | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |